Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico

Ortí, Guillermo; Sanz, Jaime; Bermúdez, Arancha; Caballero, Dolores; Martı́nez, Carmen; Sierra, Jorge; R. Cabrera Marin, José; Espigado, Ildefonso; Solano, Carlos; Ferrá, Christelle; García‐Noblejas, Ana; Jiménez, Santiago; Sampol, Antònia; Yáñez, Lucrecia; García‐Gutiérrez, Valentín; J Espinosa Pascual, M; Jurado, Manuel; M. Moraleda, José; Valcárcel, David; Á. Sanz, Miguel; Carreras, Enric; F. Duarte, Rafael

doi:10.1016/j.bbmt.2015.11.012

Public

Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico

Published in Biology of Blood and Marrow Transplantation • Nov 26, 2015

Authors:

Guillermo Ortí

Jaime Sanz

Arancha Bermúdez

Abstract

Allogeneic stem cell transplantation (allo-HCT) represents the most effective immunotherapy for acute myeloid leukemia (AML) and myeloid malignancies. However, disease relapse remains the most common cause of treatment failure. By performing a second allo-HCT, durable remission can be achieved in so...

Subject

Medicine

Hematopoietic cell

Transplantation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!